Results of a new study that compared the effectiveness of two drugs in treating heart attacks has found that one of the drugs, heparin, led to improved outcomes, including reducing the rate of repeat heart attacks, compared to bivalirudin which is a popular drug in high income countries and is 400 times more expensive than heparin. The study appears in The Lancet. The results of the HEAT-PPCI trial suggest that systematic use of heparin rather than bivalirudin after ...Saturday 5 July 2014
New Study Suggests Heparin is a Cheaper Option in Treating Common Heart Attacks
Results of a new study that compared the effectiveness of two drugs in treating heart attacks has found that one of the drugs, heparin, led to improved outcomes, including reducing the rate of repeat heart attacks, compared to bivalirudin which is a popular drug in high income countries and is 400 times more expensive than heparin. The study appears in The Lancet. The results of the HEAT-PPCI trial suggest that systematic use of heparin rather than bivalirudin after ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment